Idelalisib

Idelalisib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T1894-5mg 5 mg

7 - 10 business days*

31.00€
TGM-T1894-10mg 10 mg

7 - 10 business days*

43.00€
TGM-T1894-1mL 1 ml

7 - 10 business days*

48.00€
TGM-T1894-25mg 25 mg

7 - 10 business days*

67.00€
TGM-T1894-50mg 50 mg

7 - 10 business days*

84.00€
TGM-T1894-100mg 100 mg

7 - 10 business days*

108.00€
TGM-T1894-200mg 200 mg

7 - 10 business days*

142.00€
TGM-T1894-500mg 500 mg

7 - 10 business days*

236.00€
 
Description: Idelalisib (GS-1101) is a small molecule inhibitor of the PI3K catalytic subunit... more
Product information "Idelalisib"
Description: Idelalisib (GS-1101) is a small molecule inhibitor of the PI3K catalytic subunit p110delta (IC50: 2.5 nM). The selectivity for p110delta is 40- to 300-fold than p110alpha/beta/gamma. Target: Autophagy, PI3K. Smiles: [C@H](NC1=C2C(N=CN2)=NC=N1)(CC)C=3N(C(=O)C=4C(N3)=CC=CC4F)C5=CC=CC=C5. References: Lannutti BJ, et al. CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood. 2011 Jan 13,117(2):591-4.
Keywords: CAL-101, GS-1101
Supplier: TargetMol
Supplier-Nr: T1894

Properties

Application: Targets phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta
MW: 415.42 D
Formula: C22H18FN7O

Database Information

CAS : 870281-82-6| Matching products
KEGG ID : K00922 | Matching products
Protein Atlas Nr. : Lipid / Phosphoinositial Signaling

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Signal Word: Danger
GHS Hazard Pictograms:
H Phrases: H372
P Phrases: P260, P264, P270, P314, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Idelalisib"
Write a review
or to review a product.
Viewed